News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Stancic Ana
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/12/2015 |
4
| Stancic Ana (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns:
| Granted 50,000 options
@ $2.2, valued at
$110k
|
|
12/03/2014 |
4
| Stancic Ana (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns:
| Bought 8,000 shares
@ $2.5, valued at
$20k
Bought 2,000 warrants
@ $3.75, valued at
$7.5k
|
|
10/15/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
08/27/2013 |
3
| Stancic Ana (Director) has filed a Form 3 on IMMUNE PHARMACEUTICALS INC |
05/16/2012 |
4
| Stancic Ana (Director) has filed a Form 4 on KV PHARMACEUTICAL CO /DE/
Txns:
| Granted 20,000 options to buy
@ $0.94, valued at
$18.8k
|
|
01/19/2012 |
4/A
| Stancic Ana (Executive VP, COO, PEO CFO) has filed a Form 4 on ENZON PHARMACEUTICALS INC
Txns:
| Granted 125,000 options to buy
@ $6.37, valued at
$796.3k
|
|
01/19/2012 |
4
| Stancic Ana (Executive VP, COO, PEO, CFO) has filed a Form 4 on ENZON PHARMACEUTICALS INC
Txns:
| Disposed/sold 45,000 shares
@ $0 Granted 45,000 shares
@ $0 |
|
11/21/2011 |
4
| Stancic Ana (Executive VP, COO, PEO, CFO) has filed a Form 4 on ENZON PHARMACEUTICALS INC
Txns:
| Granted 45,000 shares
@ $0 Granted 125,000 options to buy
@ $6.37, valued at
$796.3k
|
|
09/12/2011 |
4
| Stancic Ana (Director) has filed a Form 4 on KV PHARMACEUTICAL CO /DE/
Txns:
| Granted 20,000 options to buy
@ $1.49, valued at
$29.8k
|
|
10/12/2010 |
4/A
| Stancic Ana (Director) has filed a Form 4 on KV PHARMACEUTICAL CO /DE/
Txns:
| Granted 7,500 options to buy
@ $1.14, valued at
$8.6k
|
|
09/09/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/12/2010 |
4
| Stancic Ana (Director) has filed a Form 4 on KV PHARMACEUTICAL CO /DE/
Txns:
| Granted 7,500 shares
@ $0 |
|
06/21/2010 |
3
| Stancic Ana (Director) has filed a Form 3 on KV PHARMACEUTICAL CO /DE/ |
02/23/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
09/01/2009 |
4
| Stancic Ana (Director) has filed a Form 4 on CHAMPIONS BIOTECHNOLOGY, INC. |
|
|